Possible Clinical Benefits of Cardio-Ankle Vascular Index Measurement in Urological Diseases
Emre Bulbul,Murat Oguz Ozilhan,Ali Sezer,Mustafa Yetisen,Fahri Yavuz Ilki
DOI: https://doi.org/10.2147/VHRM.S384937
2023-03-10
Vascular Health and Risk Management
Abstract:Emre Bulbul, 1 Murat Oguz Ozilhan, 2 Ali Sezer, 3 Mustafa Yetisen, 4 Fahri Yavuz Ilki 5 1 Department of Urology, Trabzon Vakf&inodotkebir State Hospital, Trabzon, Turkey; 2 Department of Cardiology, Ankara City Hospital, Ankara, Turkey; 3 Department of Urology, Konya City Hospital, Konya, Turkey; 4 Department of Cardiology, Erzurum Oltu State Hospital, Erzurum, Turkey; 5 Department of Urology, Gulhane Training and Research Hospital, Ankara, Turkey Correspondence: Emre Bulbul, Department of Urology, Trabzon Vakf&inodotkebir State Hospital, Trabzon, 61400, Turkey, Tel +90 536 390 06 11, Fax +90 462 841 35 50, Email Many factors are considered to affect vascular physiology. It is known that one of the reasons for many diseases is a pathology at the microvascular level. Therefore, the relationship between endothelial dysfunction and many diseases is currently being investigated. The clinical evaluations of arterial stiffness have made it possible to perform necessary risk assessment regarding cardiovascular diseases. In this way, protective measures can be taken against microvascular pathologies in many organs. In this paper, we present a review of studies investigating the relationship between urological conditions and the cardio-ankle vascular index (CAVI), a marker of arterial stiffness. As with erectile dysfunction, some studies have shown that conditions such as lower urinary tract symptoms, overactive bladder, and chronic kidney disease are also associated with an elevated CAVI. The association of erectile dysfunction and chronic kidney disease with vascular pathologies has been clearly demonstrated. In addition, lower urinary tract symptoms may be the first sign of silent vascular dysfunction. Assessing arterial stiffness with CAVI can help prevent future cardiovascular events in these patients. Keywords: arterial stiffness, cardio-ankle vascular index, cardiovascular disease, erectile dysfunction, lower urinary tract symptoms, overactive bladder The human body has a unique vascular anatomy, and many factors are consider to affect vascular physiology. It is known that one of the components of many diseases is a pathology at the microvascular level. 1–3 Therefore, the relationship between endothelial dysfunction and many diseases is currently being investigated. 4,5 Erectile dysfunction (ED) may be the first sign of cardiovascular disease (CVD) risk. The luminal diameter of the penile artery is smaller than that of the coronary arteries, and the erection mechanism is affected earlier by microvascular pathologies. Therefore, ED may be a marker of systemic microvascular pathologies. Furthermore, ED and CVD can be seen together with systemic vascular pathologies. 6 The European Association of Urology guidelines recommend that patients with ED be evaluated in detail regarding CVD risk. 7 In the literature, it has been stated that urological diseases, such as overactive bladder (OAB) and benign prostatic enlargement (BPE) are also associated with vascular pathologies. 8,9 It has been noted that as the local atherosclerosis of the prostatic artery increases, the prostate volume also increases. It has also been reported that oxidative stress markers are effective in the mechanism of BPE. 10 CVD risk has been found to be higher in patients with OAB. In addition, bladder neck perfusion is low on Doppler ultrasonography. As the severity of OAB increases, the Framingham risk score also increases. 11 In the literature, it has been reported that endothelial dysfunction is associated with many urological diseases, including ED, OAB, and BPE. 12–14 In clinical studies, many markers, such as brachial flow-mediated dilatation, pulse wave velocity (PWV), cardio-ankle vascular index (CAVI), and intima-media thickness have been used to measure endothelial dysfunction. 15–18 Vascular age can be determined non-invasively by measuring arterial stiffness. PWV and CAVI are indicators of arterial stiffness. 19,20 Carotid-femoral measurement is generally used to evaluate arterial stiffness with PWV. Age, rheumatological diseases and blood pressure are parameters that affect PWV independently. 21 The CAVI can also assess arterial stiffness independent of blood pressure. 22 With the clinical evaluations of arterial stiffness, necessary risk assessment can be made regarding cardiovascular diseases (Table 1). In this way, protective measures can be taken against microvascular pathologies in many organs. In this paper, we present a review of studies investigating the relationship between urological conditions and CAVI, a marker of arterial stiffness. Table 1 The Principal Finding of Each -Abstract Truncated-